Healthcare - Medical - Devices - NASDAQ - US
$ 5.24
1.35 %
$ 2.65 M
Market Cap
0.22
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
38.20%
EBIT
Estimate
18.08%
Net Income
Estimate
--992.23%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
ReShape Lifesciences Inc.
RSLS has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart RSLS
EBIT FORECAST
EBIT Forecast Chart RSLS
NET INCOME FORECAST
Net Income Chart RSLS